However, the precise role of RBM24 in gastric cancer EMT remains unclear, and further identification of RBM24-regulated alternative splicing events will be necessary in order to understand how it modulates EMT in tumor progression and whether it exerts pro-tumor or anti-tumor activity in this cancer. This evidence concerns the gene RBM24 and cancer.